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High Dose Vitamin D3 Attenuates the Hypocalciuric Effect of 
Thiazide in Hypercalciuric Rats
Thiazide is known to decrease urinary calcium excretion. We hypothesized that thiazide 
shows different hypocalciuric effects depending on the stimuli causing hypercalciuria. The 
hypocalciuric effect of hydrochlorothiazide (HCTZ) and the expression of transient receptor 
potential vanilloid 5 (TRPV5), calbindin-D28K, and several sodium transporters were assessed 
in hypercalciuric rats induced by high calcium diet and vitamin D3. Urine calcium excretion 
and the expression of transporters were measured from 4 groups of Sprague-Dawley rats; 
control, HCTZ, high calcium-vitamin D, and high calcium-vitamin D with HCTZ groups. 
HCTZ decreased urinary calcium excretion by 51.4% in the HCTZ group and only 15% in 
the high calcium-vitamin D with HCTZ group. TRPV5 protein abundance was not changed 
by HCTZ in the high calcium-vitamin D with HCTZ group compared to the high calcium-
vitamin D group. Protein abundance of NHE3, SGLT1, and NKCC2 decreased in the 
hypercalciuric rats, and only SGLT1 protein abundance was increased by HCTZ in the 
hypercalciuric rats. The hypocalciuric effect of HCTZ is attenuated in high calcium and 
vitamin D-induced hypercalciuric rats. This attenuation seems to have resulted from the 
lack of HCTZ’s effect on protein abundance of TRPV5 in severe hypercalciuric condition 
induced by high calcium and vitamin D.
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INTRODUCTION
Hypercalciuria has been known to be associated with renal stone 
(1, 2), hematuria (3, 4), and bone resorption (5) although long-
term effects of hypercalciuria have not been fully elucidated. 
Thiazides have been adopted as the treatment of choice for hy-
percalciuria. Thiazides primarily inhibit sodium-chloride cotrans-
porters (NCC) in the distal convoluted tubule and also reduce 
urinary calcium excretion (6). In addition, several reports dem-
onstrated beneficial effects of thiazides on bone mineral densi-
ty and fracture (7-9).
  The amount of urinary calcium excretion is determined by 
subtracting reabsorbed calcium from filtered calcium. Most of 
the filtered calcium is reabsorbed passively in the proximal tu-
bule (PT) and the thick ascending limb (TAL) via paracellular 
pathway driven by sodium and water reabsorption (10). And 
less than 15% of calcium is actively reabsorbed in the distal con-
voluted tubule (DCT) (11).
  There are several causes of hypercalciuria, including high salt 
or calcium diet and vitamin D administration. We previously 
reported that the down-regulation of transient receptor poten-
tial vanilloid 5 (TRPV5), sodium-hydrogen exchanger 3 (NHE3), 
sodium-glucose cotransporter 1 (SGLT1), and sodium-potassi-
um-chloride cotransporter type 2 (NKCC2) is associated with 
hypercalciuria and that thiazides decreased calcium excretion 
by 50% in hypercalciuric rats induced by high salt or high calci-
um diet (12). It has not been reported whether thiazides have a 
constant hypocalciuric effect under different settings of hyper-
calciuria. We postulated that the degree of the hypocalciuric ef-
fect of thiazides and the changes of transporters by thiazides 
would be different depending on the physiologic stimuli induc-
ing hypercalciuria. In this study, severe hypercalciuria was in-
duced by high calcium diet and intraperitoneal injection (ip) of 
vitamin D3. Vitamin D3 has been known to enhance active cal-
cium absorption in the small intestine and also stimulate calci-
um reabsorption in the kidneys (13-15).
  We assessed the hypocalciuric effect of thiazides and the 
changes of major transporters regulating urinary calcium ex-
cretion in hypercalciuric rats induced by high calcium diet and 
vitamin D3. To assess the effect of thiazides on the transporters 
participating in the passive and active calcium reabsorption 
under severe hypercalciuric condition, the expression of NHE3 Jang HR, et al.  •  Thiazide in High Calcium and Vitamin D3-induced Hypercalciuria
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and SGLT1 on the PT, NKCC2 on the TAL, and TRPV5 and cal-
bindin-D28K on the DCT was analyzed.
MATERIALS AND METHODS
Experimental protocols and measurement of physiologic 
variables
All studies were approved by Seoul National University Hospi-
tal Animal Care and Use Committee (IACUC No. 06-018). The 
experiments were performed between March 2006 and Febru-
ary 2007.
  In experiment 1, twenty specific pathogen-free male Sprague-
Dawley rats (5-6 weeks, 160-180 g; SLC, Shizuoka, Japan) were 
randomly allocated into 4 different groups: the control group, 
high calcium diet group, vitamin D group, and high calcium diet 
with vitamin D group, to find the experimental condition induc-
ing severe hypercalciuria and the adequate dosing schedule of 
vitamin D3. High calcium diet was given to the high calcium diet 
group and the high calcium diet with vitamin D group through-
out the study period. In the vitamin D group and the high calci-
um diet with vitamin D group, 0.05 μg of vitamin D3 (calcitriol; 
1,25-[OH]2-D3, Yuyu Pharma, Seoul, Korea) was injected intra-
peritonealy on day 4. Urine samples were collected on day 0, 4, 
5, and 7.
  In experiment 2, after confirming the effect high dose vitamin 
D on urine calcium excretion, twenty specific pathogen-free male 
Sprague-Dawley rats (5-6 weeks, 160-180 g; SLC) were placed 
in separate metabolic cages 3 days before the beginning of the 
study. Rats were randomly allocated into 4 groups: the control 
(N) group, the HCTZ (hydrochlorothiazide, T) group, the high 
Ca (calcium diet)–vitamin D (CD) group, and the high Ca–vita-
min D with HCTZ (CDT) group. All rats were provided with a 
daily, fixed amount of finely ground regular rat chow (14.7 g/ 
200 g of body weight per day). Drinking water containing 0.8% 
NaCl and 0.1% KCl was also provided to prevent volume deple-
tion. On day 0, osmotic mini-pumps (model 2ML1, Alzet, Palo 
Alto, CA, USA) were subcutaneously implanted to all rats under 
anesthesia with enflurane (Choongwae Pharma, Seoul, Korea). 
To induce hypercalciuria, rats in the high Ca–vitamin D group 
and the high Ca–vitamin D with HCTZ group were provided 
with rat chow containing 0.74 mM of CaCO3 (Sigma, St. Louis, 
MO, USA) per gram of chow. Rats in the control group and the 
HCTZ group were provided with regular rat chow containing a 
0.05 mM NaCl and 0.22 mM CaCO3 per gram. On days 0 and 4, 
0.05 μg of vitamin D3 (calcitriol; 1,25-[OH]2-D3) was injected in-
traperitonealy to the high Ca–vitamin D group and the high Ca–
vitamin D with HCTZ group. From day 0 to day 6, 7 mg of HCTZ 
dissolved in 1.7% ethanolamine was infused every day through 
the osmotic mini-pump to the HCTZ group and the high Ca–vi-
tamin D with HCTZ group, whereas 1.7% ethanolamine of equal 
volume was infused to the control group and the high Ca-vita-
min D group during the same period. On day 6, all rats were 
killed after bilateral nephrectomy and blood sampling under 
anesthesia using ethyl carbamate.
  Study protocol is summarized in Table 1. Body weight, water 
intake, and urine volume were measured daily. Urinary calci-
um, sodium, and creatinine were measured using the first and 
last 24-hr urine. Calcium excretion was expressed as the ratio 
between calcium and creatinine. Serum sodium level and he-
matocrit were also measured. Quantitative real-time PCR and 
semiquantitative immunoblotting were performed with the re-
nal tissue samples obtained from experiment 2.
Quantitative real-time RT-PCR
Total RNA was isolated from left kidney using TRIzol
® reagent 
(Invitrogen, Carlsbad, CA, USA). First-strand cDNA (comple-
mentary DNA) was reverse-transcribed from RNA using the 
PCR machine (PTC-200 Peltier Thermal Cycler, MJ RESEARCH, 
Watertown, MA, USA) and the Reverse Transcription System 
(Promega Corporation, Madison, WI, USA) according to the 
manufacturer’s protocols.
  Quantitative real-time PCR was performed with 1 μL of cDNA 
and master mix containing 10 μL of TaqMan
® 2×PCR Master Mix 
(Applied Biosystems, Branchburg, NJ, USA), 8 μL nuclease-free 
water, and 1 μL of probe and primer sets for TRPV5, calbindin-
D28K, sodium-hydrogen exchanger 3 (NHE3), sodium-glucose 
cotransporter 1 (SGLT1), sodium-potassium-chloride cotrans-
porter type 2 (NKCC2), and sodium-chloride cotransporter (NCC) 
(all from Applied Biosystems, Branchburg, NJ, USA) using the 
Applied Biosystems 7500 Fast Real-Time PCR System (Applied 
Biosystems, Foster City, CA, USA). Glyseraldehyde-3-phosphate 
dehydrogenase (GAPDH) was used as a house keeping gene. 
Relative quantification was assessed according to the protocols 
of the Applied Biosystems 7500 Fast Real-Time PCR System.
Semiquantitative immunoblotting
The kidneys were dissected into small pieces and placed in a 
chilled isolation buffer containing 0.3 M sucrose, 10 mM trieth-
anolamine (Sigma), 1 μg/μL leupeptin (Sigma), and 0.1 mg/μL 
phenylmethylsulfonylfluoride (Sigma) titrated to pH 7.6. Then 
the pieces were homogenized at 15,000 rpm with three stokes 
Table 1. Composition of diets and doses of vitamin D and HCTZ in each experimental 
group (n=5 in each group)
Groups
Diet (mM/g of chow)
Vitamin D HCTZ
NaCl CaCO3
N (Control) 0.05 0.22
T (HCTZ) 0.05 0.22 7 mg/d
CD (High Ca–vitamin D) 0.05 0.74 0.1 µg
CDT (High Ca–vitamin D with HCTZ) 0.05 0.74 0.1 µg 7 mg/d
Vitamin D, 0.05 µg of 1,25-(OH)2-D3 (calcitriol), was injected into the intraperitoneal 
cavity on day 0 and 4 in CD and CDT groups.
HCTZ, hydrochlorothiazide; High Ca, High calcium diet; d, day.Jang HR, et al.  •  Thiazide in High Calcium and Vitamin D3-induced Hypercalciuria
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for 15 sec with a tissue homogenizer (PowerGun 125, Fisher Sci-
entific, Pittsburgh, PA, USA). After homogenization, total protein 
concentration of the homogenate was measured by Bicinchonin-
ic acid protein assay method (BCA Reagent Kit; Sigma) and dilut-
ed to 2.50 μg/μL using the isolation buffer solution. The samples 
were then stabilized by heating to 60°C for 15 min after adding 
1 volume of 5×Laemmli sample buffer/4 volumes sample.
  Initially, “loading gels” were done on each sample set to cal-
culate the exact loading amount that would guarantee equal 
loading on subsequent immunoblots. Ten micrograms of pro-
tein from each sample were loaded into each individual lane 
and electrophoresed on 12% polyacrylamide-SDS minigels by 
using Mini-PROTEIN III electrophoresis apparatus (Bio-Rad, 
Hercules, CA, USA) and then were stained with Coomassie blue 
dye (0.025% solution made in 4.5% methanol and 1% acetic acid; 
G-250, Bio-Rad). Selected bands from these gels were scanned 
with image analyzer (Vilber Lourmat, Marne la Vallée, France) 
to semiquantitatively determine density with LabWorks version 
4.5 software (Ultra-Violet Products, Cambridge, UK) and relative 
amounts of protein loaded in each lane. Protein concentrations 
were corrected to reflect these measurements by repeating the 
process as described above.
  For semiquantitative immunoblotting, the proteins electro-
phoresed on gels were transferred from unstained gels to nitro-
cellulose membrane (Bio-Rad) using the electroelution method. 
After being blocked with 5% skim milk in PBS-T (80 mM Na2H-
PO4, 20 mM NaH2PO4, 100 mM NaCl, and 0.1% Tween-20, pH 
7.5) for 30 min, membranes were probed overnight at 4°C with 
the respective primary antibodies. Affinity–purified immuno-
globulin against TRPV5 (Chemicon International, Temecula, 
CA, USA) and affinity-purified polyclonal antibodies for calbin-
din-D28K (Alpha Diagnostic International, San Antonio, CA, USA) 
were used. The affinity-purified polyclonal antibodies against 
NKCC2 and NCC were provided by Dr. HM Kwon (University  
of Maryland, Baltimore, MD, USA), and the antibodies against 
NHE3 were provided by Dr. MA Knepper (NIH, Baltimore, MD, 
USA). Affinity-purified polyclonal antibodies against SGLT1 
(Chemicon International) were also used. For probing blots, all 
primary antibodies were diluted into a solution containing 150 
mM NaCl, 50 mM sodium phosphate, 10 mg/dL sodium azide, 
50 mg/dL Tween 20, and 0.1 g/dL bovine serum albumin (pH 
7.5). Then, the membranes were cleaned with PBS-T and prob-
ed with secondary antibodies for 1 hr at room temperature. The 
secondary antibody was horseradish peroxidase-conjugated 
donkey anti-rabbit IgG (31458; Pierce, Rockford, IL, USA) dilut-
ed to 1:3,000 except for calbindin-D28K. The secondary antibody 
for calbindin-D28K was horseradish peroxidase-conjugated rab-
bit anti-mouse IgG (31452; Pierce) diluted to 1:5,000. Antibody-
antigen reaction sites were viewed with enhanced chemilumi-
nescence system (ECLTM RPN 2106; Amersham Pharmacia 
Biotech, Buckinghamshire, UK) before exposing to radiography 
films (Hyperfilm, Amersham Pharmacia Biotech). Band density 
was measured by densitometry with LabWorks version 4.5 soft-
ware (Ultra-Violet Products Cambridge, UK) and calculated as 
a value relative to the average value of the control group.
Statistical analysis
All values are expressed as mean±standard deviation (SD). Mann-
Whitney U-test and one-way ANOVA (SPSS software; SPSS Inc., 
Chicago, IL, USA) were used to compare groups. Band density 
of immunoblots was standardized by dividing it with the aver-
age value of the control group. Thus the mean for the control 
group was defined as 100%. A P value <0.05 was considered sta-
tistically significant.
Fig. 1. Serial follow up of urine Ca/Cr ratio in high calcium diet and/or vitamin D- 
induced hypercalciuric rats. Calcitriol was injected into the peritoneal cavities of rats 
in the vitamin D group and the high Ca with vitamin D group on day 4. The urine Ca/
Cr ratio of the high Ca with vitamin D group was highest on day 5.
*P=0.01 when compared to the control group; 
†P=0.01 when compared to the high 
Ca group; 
‡P=0.01 when compared to the vitamin D group.
High Ca, high calcium diet group; vitamin D, vitamin D group; high Ca & vitamin D, 
high calcium diet with vitamin D group.
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Table 2. Body weight gain, urine volume, hematocrit, and serum sodium and creatinine concentration in high calcium diet and vitamin D-induced hypercalciuric rats
Parameters N (Control) T (HCTZ) CD (Ca-VitD) CDT (Ca-VitD with HCTZ)
Body weight gain (g)   27.60±4.39  25.35±3.39    25.20±5.12   24.80±6.70
Urine volume (mL)   11.60±2.57    21.92±3.14*    10.48±3.10      22.38±7.39*
,†
Hematocrit (%)   52.40±3.75   48.55±4.23   45.70±3.76   52.30±3.13
Serum Na (mM/L) 140.20±1.64 141.40±3.05 141.40±2.51 140.50±1.29
Serum Cr (mg/dL)     0.48±0.02     0.48±0.02     0.48±0.02     0.55±0.03
Urine volume was significantly increased in the T and CDT groups. Body weight gain, hematocrit, and serum sodium and creatinine concentration did not differ among groups.
*P=0.01 when compared to the N group; 
†P=0.02 when compared to the CD group.
VitD, vitamin D3; Na, sodium; Cr, creatinine.Jang HR, et al.  •  Thiazide in High Calcium and Vitamin D3-induced Hypercalciuria
1308   http://jkms.org DOI: 10.3346/jkms.2010.25.9.1305
RESULTS
Urinary excretion of calcium
All rats ate all of the offered rat chow and showed a steady in-
crease in body weight throughout the study period.
  In experiment 1, the greatest level of hypercalciuria was found 
in the high Ca-vitamin D group (Fig. 1). Vitamin D was injected 
in the vitamin D group and the high Ca-vitamin D group on day 
4. Urine Ca/Cr ratio of the vitamin D group and the high Ca-vi-
tamin D group significantly increased on day 5, but decreased 
on day 7 compared to day 5, but not compared to day 4.
  In experiment 2, urine Ca/Cr on day 0 was not different among 
groups (control vs. HCTZ vs. high Ca-vitamin D vs. high Ca-vita-
min D with HCTZ, 0.9±0.18 vs. 0.7±0.32 vs. 0.7±0.12 vs. 0.9±0.33). 
Changes in body weight, hematocrit, and serum sodium and 
creatinine concentration did not differ among groups (Table 2). 
Urine Ca/Cr and sodium levels are summarized in Table 3. On 
day 6, urine Ca/Cr was significantly increased in the high Ca-vi-
tamin D group (Fig. 2). In the high Ca-vitamin D with HCTZ 
group, urine Ca/Cr was decreased to about 85% of the high Ca-
vitamin D group (control vs. HCTZ vs. high Ca-vitamin D vs. 
high Ca-vitamin D with HCTZ, 1.1±0.46 vs. 0.5±0.19 vs. 3.4±0.48 
vs. 2.9±0.59).
Results of mRNA expression
Expression of TRPV5 and calbindin-D28K mRNA significantly 
decreased in the high Ca-vitamin D group, which increased 
when HCTZ was administered (Figs. 3, 4). Expression of NHE3, 
SGLT1, and NKCC2 mRNA was significantly decreased in the 
high Ca-vitamin D group, which increased when HCTZ was ad-
ministered. mRNA expression results are summarized in Table 3.
Protein abundance using semiquantitative immunoblotting
Immunoblotting for TRPV5 revealed a significant decrease of  Table 3. Urinary excretion of calcium and sodium, and expression of mRNA of calcium 
and sodium transporters in high calcium diet and vitamin D-induced hypercalciuric rats
Variables N (Control) T (HCTZ) CD (Ca-Vit.D)
CDT (Ca-Vit.D 
with HCTZ)
Urine
   Ca/Cr
   FECa (%)
   Na (mM/day)
1.07±0.46
5.82±2.74
2.48±0.61
0.52±0.19*
2.79±1.38*
4.04±0.29*
3.39±0.48*
17.30±3.31*
2.12±0.70
2.89±0.59*
15.01±3.75*
4.19±1.43*
,†
mRNA expression of calcium transporters (%)
   TRPV 5 
   Calbindin-D28K
100±32.35
100±34.33
69.12±7.35
68.66±20.90
30.88±10.29
‡
11.94±4.48*
75.00±7.35
§
67.16±16.42
§
mRNA expression of sodium transporters (%)
   NHE 3 
   SGLT 1 
   NKCC2
   NCC
100±30.43
100±50.70
100±37.61
100±12.90
42.03±18.84
‡
57.75±32.39
38.53±16.51
‡
60.22±12.90
‡
14.49±2.90*
23.94±8.45
‡
14.68±2.75*
75.27±9.68
44.93±4.35
‡,§
80.28±19.72
§
31.19±11.01
‡,§
83.87±10.75
*P=0.01 when compared to the N group; 
†P=0.04 when compared to the CD group; 
‡P=0.02 when compared to the N group; 
§P=0.02 when compared to the CD group.
FECa, Fractional excretion of calcium; TRPV5, transient receptor potential vanilloid 5; 
NHE3, sodium-hydrogen exchanger 3; SGLT1, sodium-glucose cotransporter 1; NKCC2, 
sodium-potassium-chloride cotransporter type 2; NCC, sodium-chloride cotransporter.
Fig. 2. Urine Ca/Cr ratio on day 6 in high calcium diet and vitamin D-induced hyper-
calciuric rats. Urine Ca/Cr was significantly decreased in the HCTZ group and increased 
in the high Ca-vitamin D group. In the high Ca-vitamin D with HCTZ group, urine Ca/Cr 
was decreased to about 85% of the high Ca-vitamin D group.
*P=0.01 when compared to the control group.
HCTZ, HCTZ (hydrochlorothiazide) group; Ca-VitD, high calcium diet and vitamin D 
group; Ca-VitD with HCTZ, high calcium diet and vitamin D with HCTZ group.
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Fig. 3. TRPV5 expression in high calcium diet and vitamin D-induced hypercalciuric rats. (A) TRPV5 mRNA expression was significantly decreased in the high Ca-vitamin D 
group and increased by HCTZ administration. (B) TRPV5 protein abundance was significantly increased in the HCTZ group, but decreased in both high Ca-vitamin D and high 
Ca-vitamin D with HCTZ groups.
*P=0.02 when compared to the control group; 
†P=0.02 when compared to the high Ca-vitamin D group. 
HCTZ, HCTZ (hydrochlorothiazide) group; Ca-VitD, high calcium diet and vitamin D group; Ca-VitD with HCTZ, high calcium diet and vitamin D with HCTZ group. 
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protein abundance in both high Ca-vitamin D and high Ca-vita-
min D with HCTZ groups (band density [%]; control vs. HCTZ 
vs. high Ca-vitamin D vs. high Ca-vitamin D with HCTZ, 100.0± 
19.36 vs. 148.2±5.62 vs. 71.3±16.16 vs. 49.8±15.00; Fig. 3). Protein 
abundance of calbindin-D28K showed no difference among 
groups (band density [%]; control vs. HCTZ vs. high Ca-vitamin 
D vs. high Ca-vitamin D with HCTZ, 100.0±3.69 vs. 88.0±8.23 vs. 
95.0±7.29 vs. 102.3±20.70; Fig. 4). Protein abundance of NHE3, 
NKCC2, and NCC was decreased in the high Ca-vitamin D group 
and was not changed by HCTZ. In the high Ca-vitamin D with 
HCTZ group, HCTZ increased protein abundance of SGLT1 which 
was decreased in the high Ca-vitamin D group (Fig. 5).
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Fig. 4. Calbindin-D28K expression in high calcium diet and vitamin D-induced hypercalciuric rats. (A) Expression of calbindin-D28K mRNA was significantly decreased in the high 
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 DISCUSSION
In our experiment, high calcium diet and vitamin D3 decreased 
protein abundance of TRPV5, NHE3, SGLT1, and NKCC2, re-
sulting in severe hypercalciuria and the expression of TRPV5, 
NHE3, and NKCC2 was not restored by HCTZ administration. 
These results support that hypercalciuria is caused by dysregu-
lation of several stages of calcium transportation in the kidneys 
(16) and the hypocalciuric effect of HCTZ is attenuated in severe 
hypercalciuric condition induced by high calcium diet and vita-
min D3.
  Several previous reports described the regulation of TRPV5 
and TRPV6 by vitamin D3 (15, 17-20) and estrogen (17, 21). Ho-
enderop et al. reported that TRPV5 is an important target of ac-
tive vitamin D3 and is positively controlled by vitamin D3 through 
experiments using vitamin D-deficient diet (15) and 25-hydro-
xyvitamin D3-1α-hydroxylase knockout mice (19). Renkema et 
al. showed that hypervitaminosis D plays a crucial role in main-
taining normocalcemia in TRPV5 knockout mice (20). In this 
study, male rats were used to minimize the effect of estrogen on 
TRPV5 expression and high calcium diet with vitamin D was 
administered to elucidate the effect of supraphysiologic vitamin 
D3 on the hypocalciuric effect of thiazide. High calcium diet was 
used to ascertain that all rats have the same concentration of 
1,25-(OH)2-D3 after calcitriol ip, because high calcium diet itself 
would suppress the endogenous production of vitamin D3 and 
abolish the blood level variation of endogenous vitamin D3 (22). 
Under physiologic conditions, increased calcium is regulated 
via a negative feedback mechanism that eventually leads to sup-
pression of 1α-hydroxylase activity which in turn decreases cal-
cium reabsorption and expression of calcium transport proteins 
(17).
  When high calcium diet and supraphysiologic vitamin D3 were 
administered concomitantly, severe hypercalciuria was induced 
and TRPV5 expression was suppressed in protein levels. Con-
comitant administration of high calcium diet and vitamin D3 
also decreased protein abundance of NHE3, SGLT1, NKCC2, 
and NCC. This suggests that both active calcium reabsorption 
via TRPV5 and passive calcium reabsorption driven by solvent 
drag via sodium transporters are impaired in severe hypercalci-
uric condition induced by high calcium and vitamin D3.
  Our study revealed a different hypocalciuric effect of thiazide 
with regard to various physiologic conditions. In the HCTZ group, 
HCTZ increased protein abundance of TRPV5 and decreased 
urinary calcium excretion by 51.4% compared to the control 
group. However, in the high Ca-vitamin D with HCTZ group, 
HCTZ decreased urinary calcium excretion by 15% compared 
to the high Ca-vitamin D group and did not affect the protein 
abundance of TRPV5. HCTZ increased the protein abundance 
of TRPV5 and subsequently decreased urinary calcium excre-
tion by 50% in the hypercalciuric rats induced with high calci-
um diet in our previous study (12). The amount calcium in the 
high calcium diet was the same in our current and previous 
studies. Therefore, the administration of high dose vitamin D3 
seems to attenuate the hypocalciuric effect of HCTZ by induc-
ing persistent down-regulation of TRPV5.
  There have been several distinct hypotheses concerning the 
hypocalciuric effect of HCTZ. Nijenhuis et al. suggested that ex-
tracellular volume contraction was a critical determinant of 
HCTZ-induced hypocalciuria and the expression of Ca
2+ trans-
porters was decreased under the HCTZ treatment, which is not 
concordant with our results (23). However, much higher dose of 
HCTZ compared to the dose of HCTZ in our study was utilized 
in their study and high dose of HCTZ might reduce distal con-
voluted tubule (DCT) density itself resulting in the decrement 
of Ca
2+ transporters because a similar dose of HCTZ was report-
ed to induce apoptosis in the DCT cells (24). There was a report 
showing that enhanced passive calcium reabsorption is more 
important for HCTZ-induced hypocalciuria than active calcium 
reabsorption using TRPV5 knockout mice (25). Lee et al. pro-
posed that HCTZ induces hypocalciuria through different mech-
anisms depending on volume status (26). They reported that 
HCTZ-induced hypocalciuria seems to be achieved through the 
increased expression of TRPV5 under euvolemic condition and 
this is consistent with our previous report. In our previous report, 
we suggested that TRPV5 is a critical determinant of the hypo-
calciuric effect of chronic HCTZ treatment (12). There were also 
a report demonstrating the essential role of TRPV5 in calcium 
homeostasis using TRPV5-null mice (27), and another report 
showing that the gatekeeper function of TRPV5 is the rate-lim-
iting step in active calcium reabsorption using single- and dou-
ble-knockout mice lacking TRPV5 and calbindin-D28K (28).
  Our current data showed that HCTZ did not affect protein 
abundance of TRPV5 in high calcium diet and vitamin D-in-
duced severe hypercalciuric rats, resulting in small reduction of 
urinary calcium excretion. In this study, the rats were provided 
with drinking water containing 0.8% NaCl and 0.1% KCl to pre-
vent volume depletion, and measured data such as weight gain, 
hematocrit, and serum sodium concentration showed no dif-
ference among groups, reflecting a comparable volume status. 
Our results imply that the attenuation of HCTZ’s hypocalciuric 
effect is caused by persistently decreased protein abundance of 
TRPV5 after HCTZ administration in high calcium diet and vita-
min D-induced hypercalciuric rats. And increased protein abun-
dance of SGLT1 by HCTZ seems to be responsible for the small 
reduction of urinary calcium excretion.
  There were some discrepancies between mRNA expression 
and protein abundance of transporters, probably resulting from 
negative feedback by protein abundance, post-transcriptional 
mechanisms, or from the time difference between mRNA ex-
pression and protein production. We performed a preliminary 
study with immunohistochemistry of NKCC2 and NCC and there Jang HR, et al.  •  Thiazide in High Calcium and Vitamin D3-induced Hypercalciuria
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was no difference in the expression of NKCC2 and NCC between 
groups. These discrepancies between protein abundance mea-
sured with immunoblotting and immunohistochemistry may 
be due to the difference in sample preparation, since immunob-
lotting was performed with protein samples made from whole 
kidney tissue whereas immunohistochemistry was performed 
on a piece of renal section.
  In conclusion, we demonstrated that concomitant adminis-
tration of high calcium diet and high dose vitamin D3 induces 
severe hypercalciuria by decreasing protein abundance of TRPV5 
and major sodium transporters participating in passive calcium 
reabsorption. We also revealed that the hypocalciuric effect of 
HCTZ is attenuated in high calcium diet and vitamin D-induced 
hypercalciuric rats, probably caused by persistently decreased 
TRPV5 protein abundance. Our data suggest that the hypocal-
ciuric effect of HCTZ may vary depending on the type of physi-
ologic stimuli.
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